retatrutide 3 receptors There's a new name in the GLP conversation — and it's worth paying attention to. is a triple-agonist therapy that targets GLP-1, GIP, and glucagon simultaneously. In clinical trials, it retatrutide triple hormone receptor agonist
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
























